Literature DB >> 25550400

Imaging vessel wall biology to predict outcome in abdominal aortic aneurysm.

Reza Golestani1, Mahmoud Razavian1, Lei Nie1, Jiasheng Zhang1, Jae-Joon Jung1, Yunpeng Ye1, Michelle de Roo1, Koen Hilgerink1, Chi Liu1, Simon P Robinson1, Mehran M Sadeghi2.   

Abstract

BACKGROUND: Abdominal aortic aneurysm (AAA) rupture risk is currently determined based on size and symptoms. This approach does not address the rupture risk associated with small aneurysms. Given the role of matrix metalloproteinases (MMPs) in AAA weakening and rupture, we investigated the potential of MMP-targeted imaging for detection of aneurysm biology and prediction of outcome in a mouse model of AAA with spontaneous rupture. METHODS AND
RESULTS: Fifteen-week-old mice (n=66) were infused with angiotensin II for 4 weeks to induce AAA. Saline-infused mice (n=16) served as control. The surviving animals underwent in vivo MMP-targeted micro-single photon emission computed tomographic/computed tomographic imaging, using RP805, a technetium-99m-labeled MMP-specific tracer, followed by ex vivo planar imaging, morphometry, and gene expression analysis. RP805 uptake in suprarenal aorta on micro-single photon emission computed tomographic images was significantly higher in animals with AAA when compared with angiotensin II-infused animals without AAA or control animals. CD68 expression and MMP activity were increased in AAA, and significant correlations were noted between RP805 uptake and CD68 expression or MMP activity but not aortic diameter. A group of angiotensin II-infused animals (n=24) were imaged at 1 week and were followed up for additional 3 weeks. RP805 uptake in suprarenal aorta at 1 week was significantly higher in mice that later developed rupture or AAA. Furthermore, tracer uptake at 1 week correlated with aortic diameter at 4 weeks.
CONCLUSIONS: MMP-targeted imaging reflects vessel wall inflammation and can predict future aortic expansion or rupture in murine AAA. If confirmed in humans, this may provide a new paradigm for AAA risk stratification.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  aneurysm; inflammation; matrix metalloproteinases; molecular imaging

Mesh:

Substances:

Year:  2014        PMID: 25550400      PMCID: PMC4284949          DOI: 10.1161/CIRCIMAGING.114.002471

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  38 in total

Review 1.  Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-06-23       Impact factor: 32.419

Review 2.  SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary.

Authors:  Elliot L Chaikof; David C Brewster; Ronald L Dalman; Michel S Makaroun; Karl A Illig; Gregorio A Sicard; Carlos H Timaran; Gilbert R Upchurch; Frank J Veith
Journal:  J Vasc Surg       Date:  2009-10       Impact factor: 4.268

3.  Deaths: preliminary data for 2009.

Authors:  Kenneth D Kochanek; Jiaquan Xu; Sherry L Murphy; Arialdi M Miniño; Hsiang-Ching Kung
Journal:  Natl Vital Stat Rep       Date:  2011-03

Review 4.  Emergence of molecular imaging of aortic aneurysm: implications for risk stratification and management.

Authors:  Reza Golestani; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2014-01-01       Impact factor: 5.952

Review 5.  (18)F-FDG PET and vascular inflammation: time to refine the paradigm?

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2015-04       Impact factor: 5.952

6.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo.

Authors:  Mahmoud Razavian; Jiasheng Zhang; Lei Nie; Sina Tavakoli; Niema Razavian; Lawrence W Dobrucki; Albert J Sinusas; D Scott Edwards; Michael Azure; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

8.  Lipid lowering and imaging protease activation in atherosclerosis.

Authors:  Mahmoud Razavian; Lei Nie; Azariyas Challa; Jiasheng Zhang; Reza Golestani; Jae-Joon Jung; Simon Robinson; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2013-12-25       Impact factor: 5.952

Review 9.  Contribution of PET scanning to the evaluation of abdominal aortic aneurysm.

Authors:  Natzi Sakalihasan; Roland Hustinx; Raymond Limet
Journal:  Semin Vasc Surg       Date:  2004-06       Impact factor: 1.000

10.  TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice.

Authors:  Yu Wang; Hafid Ait-Oufella; Olivier Herbin; Philippe Bonnin; Bhama Ramkhelawon; Soraya Taleb; Jin Huang; Georges Offenstadt; Christophe Combadière; Laurent Rénia; Jason L Johnson; Pierre-Louis Tharaux; Alain Tedgui; Ziad Mallat
Journal:  J Clin Invest       Date:  2010-01-25       Impact factor: 14.808

View more
  20 in total

1.  Molecular cardiovascular imaging is ready for prime time: almost there.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2016-02-10       Impact factor: 5.952

3.  CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction.

Authors:  Sean J English; Sergio E Sastriques; Lisa Detering; Deborah Sultan; Hannah Luehmann; Batool Arif; Gyu Seong Heo; Xiaohui Zhang; Richard Laforest; Jie Zheng; Chieh-Yu Lin; Robert J Gropler; Yongjian Liu
Journal:  Circ Cardiovasc Imaging       Date:  2020-03-13       Impact factor: 7.792

4.  Playing slot to hitting the jackpot in molecular imaging: On probability of uncovering subcellular pathogenesis vs achieving clinical applicability.

Authors:  Hans J de Haas; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2017-03-28       Impact factor: 5.952

Review 5.  Multi-modality molecular imaging of aortic aneurysms.

Authors:  Brian J Malm; Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2017-04-26       Impact factor: 5.952

6.  Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging.

Authors:  Jakub Toczek; Thomas Bordenave; Kiran Gona; Hye-Yeong Kim; Fabrice Beau; Dimitris Georgiadis; Isabelle Correia; Yunpeng Ye; Mahmoud Razavian; Jae-Joon Jung; Olivier Lequin; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  J Med Chem       Date:  2019-10-25       Impact factor: 7.446

7.  Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.

Authors:  Jakub Toczek; Yunpeng Ye; Kiran Gona; Hye-Yeong Kim; Jinah Han; Mahmoud Razavian; Reza Golestani; Jiasheng Zhang; Terence L Wu; Jae-Joon Jung; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2017-03-30       Impact factor: 10.057

8.  Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.

Authors:  Thomas Bordenave; Marion Helle; Fabrice Beau; Dimitris Georgiadis; Livia Tepshi; Mylène Bernes; Yunpeng Ye; Laure Levenez; Enora Poquet; Hervé Nozach; Mahmoud Razavian; Jakub Toczek; Enrico A Stura; Vincent Dive; Mehran M Sadeghi; Laurent Devel
Journal:  Bioconjug Chem       Date:  2016-09-14       Impact factor: 4.774

9.  Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.

Authors:  Reza Golestani; Mahmoud Razavian; Yunpeng Ye; Jiasheng Zhang; Jae-Joon Jung; Jakub Toczek; Kiran Gona; Hye-Yeong Kim; Jack A Elias; Chun Geun Lee; Robert J Homer; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2016-07-28       Impact factor: 10.057

Review 10.  Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.

Authors:  Jonathan Vigne; James Thackeray; Jeroen Essers; Marcus Makowski; Zoreh Varasteh; Adelina Curaj; Angelos Karlas; Emmanuel Canet-Soulas; Willem Mulder; Fabian Kiessling; Michael Schäfers; René Botnar; Moritz Wildgruber; Fabien Hyafil
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.